MedTrace Logo

Effects of Daytime Eszopiclone Administration in Shift Workers

NCT00900159 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2017-08-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test the effects of eszopiclone on daytime sleep and overnight wakefulness in shift workers.

Conditions

  • Shift-Work Sleep Disorder

Interventions

DRUG

eszopiclone

3mg eszopiclone prior to daytime sleep for 3 days (at home) and 1 day (in lab)

DRUG

matching placebo

matching placebo prior to daytime sleep for 3 days (at home) and 1 day (in lab)

Sponsors & Collaborators

  • Sumitomo Pharma America, Inc.

    collaborator INDUSTRY

  • Massachusetts General Hospital

    collaborator OTHER

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Orfeu M Buxton, Ph.D. · Brigham and Women's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2010-01-31
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00900159 on ClinicalTrials.gov